These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1146 related items for PubMed ID: 9295029

  • 1. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X, Bavari S, Ulrich R, Sadegh-Nasseri S, Ferrone S, McHugh L, Mage M.
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [Abstract] [Full Text] [Related]

  • 2. Directed evolution of soluble single-chain human class II MHC molecules.
    Esteban O, Zhao H.
    J Mol Biol; 2004 Jun 25; 340(1):81-95. PubMed ID: 15184024
    [Abstract] [Full Text] [Related]

  • 3. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE, Brehm RD, Tranter H, Warrens AN, Lombardi G, Lechler RI.
    Eur J Immunol; 1995 Dec 25; 25(12):3437-44. PubMed ID: 8566035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR, Teletski CL, Scholl P, Geha R, Long EO.
    Nature; 1990 Aug 02; 346(6283):474-6. PubMed ID: 2377209
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR, Sekaly RP, Diez A, Glimcher LH, Geha RS.
    Eur J Immunol; 1990 Sep 02; 20(9):1911-6. PubMed ID: 2209697
    [Abstract] [Full Text] [Related]

  • 9. Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain.
    Lee L, McHugh L, Ribaudo RK, Kozlowski S, Margulies DH, Mage MG.
    Eur J Immunol; 1994 Nov 02; 24(11):2633-9. PubMed ID: 7957555
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins.
    Dowd JE, Jenkins RN, Karp DR.
    J Immunol; 1995 Feb 01; 154(3):1024-31. PubMed ID: 7822779
    [Abstract] [Full Text] [Related]

  • 11. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E, Horváth A, Gogolák P, Tóth GK, Fazekas G, Fridkin M, Pecht I.
    Eur J Immunol; 1997 Dec 01; 27(12):3105-14. PubMed ID: 9464794
    [Abstract] [Full Text] [Related]

  • 12. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
    Barber LD, Lechler RI.
    J Immunol; 1991 Oct 01; 147(7):2346-53. PubMed ID: 1717556
    [Abstract] [Full Text] [Related]

  • 13. Production of soluble MHC class II proteins with covalently bound single peptides.
    Kozono H, White J, Clements J, Marrack P, Kappler J.
    Nature; 1994 May 12; 369(6476):151-4. PubMed ID: 8177320
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. T cell recognition of allopeptides in context of syngeneic MHC.
    Liu Z, Braunstein NS, Suciu-Foca N.
    J Immunol; 1992 Jan 01; 148(1):35-40. PubMed ID: 1530797
    [Abstract] [Full Text] [Related]

  • 16. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JB.
    J Immunol; 1991 Aug 15; 147(4):1292-8. PubMed ID: 1869824
    [Abstract] [Full Text] [Related]

  • 17. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
    Vogt AB, Stern LJ, Amshoff C, Dobberstein B, Hämmerling GJ, Kropshofer H.
    J Immunol; 1995 Nov 15; 155(10):4757-65. PubMed ID: 7594477
    [Abstract] [Full Text] [Related]

  • 18. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
    Nag B, Wada HG, Passmore D, Clark BR, Sharma SD, McConnell HM.
    J Immunol; 1993 Feb 15; 150(4):1358-64. PubMed ID: 8432982
    [Abstract] [Full Text] [Related]

  • 19. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
    Seth A, Stern LJ, Ottenhoff TH, Engel I, Owen MJ, Lamb JR, Klausner RD, Wiley DC.
    Nature; 1994 May 26; 369(6478):324-7. PubMed ID: 8183371
    [Abstract] [Full Text] [Related]

  • 20. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
    Geluk A, Bloemhoff W, De Vries RR, Ottenhoff TH.
    Eur J Immunol; 1992 Jan 26; 22(1):107-13. PubMed ID: 1370411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.